Dr. Olivier Clément, PhD, and Dr. Pierre-Henri Lefevre[email protected]Clinical NewsGadolinium chelates for MRI: Where are we now?The safety of MRI contrast agents came under close scrutiny at the Journées Francophones de Radiologie congress. Dr. Olivier Clément, PhD, from Paris and Dr. Pierre-Henri Lefevre from Nîmes provided timely summaries of the current and future status of these products and asked what the literature tells us.October 17, 2016Page 1 of 1Top StoriesMRISwiss-led team shines light on training in prostate MRITraining in prostate multiparametric MRI interpretation results in similar levels of competence for urology and radiology trainees, according to a new study.UltrasoundT1/T2-weighted MRgFUS ratio imaging improves brain lesion contrastDigital X-RayDark-field radiography improves detection of pneumothoraxRadiation Oncology/TherapyWhy we must celebrate Charles Joslin's remarkable lifeMRIMRI safety and radiation-induced cancer risks dominate in 2025